TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Scanfarma AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
10,503
|
10,110
|
9,820 |
| Financial expenses |
0
|
6
|
1 |
| Earnings before taxes |
-3,290
|
760
|
528 |
| EBITDA |
-3,269
|
728
|
526 |
| Total assets |
4,533
|
7,613
|
7,567 |
| Current assets |
4,294
|
7,355
|
7,567 |
| Current liabilities |
967
|
890
|
1,378 |
| Equity capital |
1,495
|
4,665
|
3,905 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
3
|
5
|
6 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
33.0%
|
61.3%
|
51.6% |
| Turnover per employee |
3,501
|
2,022
|
1,637 |
| Profit as a percentage of turnover |
-31.3%
|
7.5%
|
5.4% |
| Return on assets (ROA) |
-72.6%
|
10.1%
|
7.0% |
| Current ratio |
444.1%
|
826.4%
|
549.1% |
| Return on equity (ROE) |
-220.1%
|
16.3%
|
13.5% |
| Change turnover |
210
|
-407
|
-1,213 |
| Change turnover % |
2%
|
-4%
|
-11% |
| Chg. No. of employees |
-2
|
-1
|
-1 |
| Chg. No. of employees % |
-40%
|
-17%
|
-14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.